Single-Dose Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1
Clinical trial NCT03461289 · COMPLETED
Trial details
- NCT number
- NCT03461289
- Sponsor
- Novartis Gene Therapies
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-16
- Primary completion
- 2020-09-11
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.